Sidra Medicine Hosts Inaugural Conference on Primary Immune Dysregulation Disorders 15 May 2024, Doha, Qatar – Sidra Medicine, in collaboration with the MENAT-NIAID initiative, proudly hosted the Recent Advances in Primary Immunodysregulation Disorders (RAPID) conference on the 9th a… Continue Reading.....

Sidra Medicine to Establish Qatar’s First-Ever Pediatric Hematopoietic Stem Cell Transplant Program QF Entity Partners with Children’s Hospital of Philadelphia 14 May 2024, Doha, Qatar – Sidra Medicine, a QF entity, is proud to announce the upcoming establishment of the first-ever pediatric hemat… Continue Reading.....

Sidra Medicine Leads Largest Research on Rare Genetic Disease Risk in the Middle East 22 April 2024, Doha, Qatar – A study by Sidra Medicine, a member of Qatar Foundation, on rare genetic diseases in a wide-ranging and diverse Middle Eastern cohort from Qatar, has been published in the… Continue Reading.....

First Arab Middle Eastern Genetics Research in Autism Going Global Thanks to Qatar’s Sidra Medicine, we now have a better understanding of Middle Eastern Genetics and their Implications for ASD     1 April 2024, Doha, Qatar – On World Autism Awarene… Continue Reading.....

Sidra Medicine Appoints Wouter Van den Brande as New Chief Operating Officer 12 March 2024, Doha, Qatar – Sidra Medicine has appointed Mr. Wouter Van den Brande as its new Chief Operating Officer (COO). As COO of Sidra Medicine, Wouter's responsibilities will include overse… Continue Reading.....

Sidra Medicine Empowers Rare Disease Research QF Entity opens accessibility to state-of-the-art research services 28 February 2024, Doha, Qatar – In support of Rare Disease Day, Sidra Medicine today announced the accessibility of its unique an… Continue Reading.....